SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: yosid who wrote (1561)1/26/2000 2:14:00 PM
From: Sun Tzu  Read Replies (1) of 1754
 
There are several problems with VISX, which can be summed up as uncertainity. It is not that they are gauranteed to fail, but that they promised they were as safe as money in the bank and have been proven wrong. So who knows how wrong. Here are the issues:

(a) The patents are not as air-tight as VISX had people believe. This means that they are open to competition and therefore price errosion.

(b) There is a shortage of "good" doctors, which limits the amount of operations and therefore VISX's growth rate.

(c) There is now a serious threat that VISX will have to give up on their per-usage fee model due to competitative pressures.

For what it's worth, I think VISX can maintain a technological lead or at least be up there. But that does not solve the above pressures. The market is trying to price in above margin and growth rate pressures and compensate for the risks. And no I don't think VISX will bounce back as fast as it fell, no matter what the good news. Now if the down trend continues over the next few days, then I'll actually go against the trend. Otherwise I'd wait for some stability before buying.

ST
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext